Addendum: Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc

Emily K Ninmer1, Hong Zhu2,3, Kimberly A Chianese-Bullock1,3

  • 1Department of Surgery/Division of Surgical Oncology and the Human Immune Therapy Center, Cancer Center, University of Virginia, Charlottesville, VA, USA.

Nature Communications
|September 5, 2025
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos